Pure Global
NCT06310655

Online Proton Adaptive Radiotherapy

A Novel Pilot Study of Online Proton Adaptive RadioTherapY (PARTy) Utilizing Computed Tomography On Rails
Washington University School of Medicine·ClinicalTrials.gov·radiationRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Solid Tumor
Drug/Device/Intervention
Proton SBRT
Study type
Interventional
Intervention type
radiation
Sponsor & location
Primary sponsor
Washington University School of Medicine
Location
Saint Louis, United States of America
Timeline & enrollment
Phase
N/A
Start date
May 02, 2024
End date
Aug 31, 2025
Enrollment
10 participants
Primary outcome

Feasibility of online proton adaptive radiotherapy

Summary

This is a pilot study evaluating the feasibility of daily online adaptive planning for
 patients undergoing proton radiation therapy.
 
 Patients undergoing proton radiation therapy normally undergo extensive pre-planning for
 their treatment. However, accounting for uncertainties in treatment delivery remains a
 challenge for a variety of reasons, such as differences in patient anatomy from pre-planning
 to the day of treatment. Online adaptive planning is a process consisting of generating the
 original pre-plan on the patient on a treatment day, assessing the pre-plan's coverage and
 safety, and if changes are needed, the plan is changed in order to optimize the treatment
 while the patient is still on the treatment table. This study is assessing the feasibility
 and safety of this approach in order to gather data for a larger trial.

ICD-10 classifications
Malignant neoplasm: Connective and soft tissue, unspecifiedCarcinoma in situ, unspecifiedMalignant neoplasm: ParametriumMalignant neoplasm of other connective and soft tissueMalignant neoplasm: Lip, unspecified, inner aspect
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06310655
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06310655 through Pure Global AI's free database. This phase not specified trial is sponsored by Washington University School of Medicine and is currently Recruiting. The study focuses on Solid Tumor. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.